SCHEMBL9478317

SCHEMBL9478317

CC1=CCC[C@H]2[C@](C)(Cc3cc(O)ccc3OC(=O)CCC(=O)O)[C@@H](C)CC[C@]12C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 12/20 0.78
PTGS2 P35354 3/20 0.65
CETP P11597 1/20 0.65
IGF1R P08069 2/20 0.53
SRC P12931 2/20 0.53
AXL P30530 2/20 0.53
KDR P35968 2/20 0.53
PTK2 Q05397 2/20 0.53
ALK Q9UM73 2/20 0.53
NUAK1 O60285 1/20 0.53
MET P08581 1/20 0.53
PIM1 P11309 1/20 0.53
AKT1 P31749 1/20 0.53
NEK2 P51955 1/20 0.53
PLK1 P53350 1/20 0.53
AURKB Q96GD4 1/20 0.53
NEK6 Q9HC98 1/20 0.53
PTPN6 P29350 3/20 0.51
ACLY P53396 3/20 0.51
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9479229 0.81 PTPN1 (1.00) PTPN1PTGS2CETPIGF1RSRC
Avarol SCHEMBL31517137 0.80 PTPN1 (1.00) PTPN1PTGS2CETPIGF1RSRC
SCHEMBL31536096 0.79 PTPN1 (0.84) PTPN1PTGS2CETPIGF1RSRC
Avarol SCHEMBL9477102 0.79 PTPN1 (0.98) PTPN1PTGS2CETPIGF1RSRC
SCHEMBL31536047 0.74 PTPN1 (1.00) PTPN1PTGS2CETPIGF1RSRC
SCHEMBL31536035 0.68 PTPN1 (0.62) PTPN1PTGS2CETPIGF1RSRC
SCHEMBL31536088 0.67 PTPN1 (0.68) PTPN1PTGS2CETPIGF1RSRC
SCHEMBL31536175 0.65 ALOX5 (0.56) PTPN1PTGS2CETPIGF1RSRC
Kolavenic Acid SCHEMBL34463382 0.65 HPGD (1.00) PTPN1PTGS2CETPIGF1RSRC
Isospongiaquinone SCHEMBL31536073 0.63 ALOX5 (0.66) PTPN1PTGS2CETPIGF1RSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5180748-A Antitumor agents MERZ+CO. GMBH & CO. (DE) 1993-01-19 US disclosed
US-5082865-A Avarol and its production and use as an antitumor agent (I) MUELLER WERNER E G (DE) 1992-01-21 US disclosed
US-4946869-A IN THE FORMS OF TABLETS, CAPSULES, ELIXIRS, SUPPOSITORIES OR STERILE INJECTABLE SOLUTIONS MERZ AND CO. GMBH & CO. (DE) 1990-08-07 US disclosed
US-4939178-A Use of avarol for the control of adult T-cell leukemia/lymphoma MERZ + CO. GMBH & CO. (DE) 1990-07-03 US disclosed
US-4939177-A Use of avarol for the control of AIDS and ARC MERZ + CO. GMBH & CO. (DE) 1990-07-03 US disclosed
EP-0252305-A2 Use of avarone and avarol and derivatives thereof for the preparation of a pharmaceutical composition for the control of adult T-cell leukemia/lymphoma Merz & Co. GmbH & Co. (DE) 1988-01-13 EP disclosed
EP-0252304-A2 Use of avarone and avarol and derivatives thereof for the preparation of a pharmaceutical composition for the control of AIDS and ARC Merz & Co. GmbH & Co. (DE) 1988-01-13 EP disclosed